In a first-of-its-kind clinical trial, U.S. researchers found that people with agitation and dementia in late life who took a special medical formulation of two active ingredients found in marijuana—THC and CBD—had significantly ...
3 hours ago
0
2
Up to 60% of people with Alzheimer's disease experience agitation, a symptom that can be a significant burden for caregivers. Nondrug treatments are recommended as first-line interventions. Citalopram, a selective serotonin ...
Apr 1, 2025
0
17
A synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer's, new research shows.
Sep 30, 2024
0
23
Big pops of noise and light are always a part of Independence Day celebrations.
Jul 1, 2024
0
36
A new study from Duke-NUS Medical School has highlighted the widespread use of physical restraints among caregivers of older adults with advanced dementia living at home, revealing a need for better guidance and alternative ...
Jun 17, 2024
0
50
Although service members know they may lose their lives in combat in service of their country, they may not expect to lose their lives—or those they love—to suicide. A 2021 study estimated that four times as many active duty ...
May 23, 2024
0
31
Quality of life for people with dementia living in residential and nursing home care substantially improved after staff took part in a digital training program that was specially adapted to COVID-19 restrictions. The training ...
Dec 20, 2023
0
48
Alzheimer's disease, the most common form of dementia, affects millions of lives worldwide, robbing patients of their memories and thinking abilities.
Jun 15, 2023
0
38
A medication to treat agitation in Alzheimer's patients now has approval from the U.S. Food and Drug Administration.
May 12, 2023
0
74
Dementia has overtaken coronary heart disease as the leading cause of disease burden among Australians aged 65 and over.
Feb 23, 2023
0
38
